Respiratory syncytial virus and bronchiolitis
The clinical research activity is centered on prevention of RSV bronchiolitis and related respiratory morbidity in vulnerable infants, with attention to outcomes linked to early-life respiratory infection.
- Respiratory syncytial virus infection
- Bronchiolitis prevention
- Infant respiratory outcomes
Interest extends to the clinical burden of lower respiratory tract disease in early infancy and the reduction of subsequent respiratory complications.
Prematurity and neonatal respiratory health
Research activity includes preterm infants born at late preterm gestational ages, focusing on respiratory vulnerability in otherwise healthy neonates and the clinical consequences of prematurity-related susceptibility.
- Late preterm birth
- Neonatal respiratory vulnerability
- Infant morbidity
The sponsor’s interest is directed toward respiratory health in the neonatal period, particularly in infants at increased risk for infection-related complications.
Infectious disease prevention
The funded research landscape reflects a focus on preventing infection-associated respiratory complications in infants, with emphasis on reducing the impact of viral illness on early childhood health.
- Viral respiratory prevention
- Infant infection-related morbidity
- Preventive pediatric care
Clinical interest includes strategies aimed at limiting the downstream effects of respiratory infections in a neonatal population.
